FDA seeks more data on Acura's abuse-resistant pain drug

August 15, 2014 11:40 AM

13 0

(Reuters) - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.

The FDA in May said data was insufficient to support the company's claim that the drug could not be abused by snorting.

Also read: Deutsche Bank Gets a Much-Needed Boost Working for Big Tobacco

Read more

To category page